NEW AMSTERDAM PARTNERS LLC/NY - IMPAX LABORATORIES INC ownership

IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 161 filers reported holding IMPAX LABORATORIES INC in Q3 2014. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
NEW AMSTERDAM PARTNERS LLC/NY ownership history of IMPAX LABORATORIES INC
ValueSharesWeighting
Q1 2016$8,863,000
-15.9%
276,784
+23.1%
0.93%
+9.3%
Q1 2015$10,534,000
+20.4%
224,754
-18.6%
0.85%
+11.7%
Q4 2014$8,749,000
-52.3%
276,169
-64.3%
0.76%
-38.0%
Q3 2014$18,354,000
-12.0%
774,092
+11.4%
1.23%
-9.5%
Q2 2014$20,846,000695,1001.36%
Other shareholders
IMPAX LABORATORIES INC shareholders Q3 2014
NameSharesValueWeighting ↓
Orbimed Advisors 5,415,600$162,414,0001.91%
Broadfin Capital, LLC 1,217,858$36,524,0001.80%
NEW AMSTERDAM PARTNERS LLC/NY 695,100$20,846,0001.36%
Healthcare Value Capital, LLC 50,000$1,500,0001.26%
Iguana Healthcare Management, LLC 75,000$2,249,0001.05%
Matarin Capital Management, LLC 78,292$2,347,977,0001.04%
Independence Capital Asset Partners, LLC 253,089$7,590,0001.04%
Tekla Capital Management LLC 344,683$10,337,0000.95%
Penn Capital Management Company, LLC 794,641$23,831,0000.92%
Leonard Capital Management, Inc. 87,661$2,629,0000.89%
View complete list of IMPAX LABORATORIES INC shareholders